Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Barry Jacobson (NPI 1275679250)

Field	Value
Entity Type	Individual
Organization	Barry Jacobson
Address	1020 Baltimore Pike Ste 220
City	Glen Mills
State	PA
ZIP	19342
Taxonomy	Obstetrics & Gynecology Physician
NPI Enumerated	January 29, 2007

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the material business line: lifetime Medicare revenue is $3M while Medicaid billing is listed as none, indicating the provider operates as effectively single‑payer (Medicare) in the available records. The absence of Medicaid claims on file means any Medicaid-facing volumes or revenue streams are negligible or not submitted under this NPI.

Revenue is highly concentrated in three Medicare codes: J3111 (57.4%), J0897 (36.8%), and 99214 (2.2%), which together account for 96.4% of this provider’s total Medicare revenue. That concentration indicates the practice’s financial model is driven overwhelmingly by a small set of services rather than a broad mix of office-based E/M care.

The top revenue codes point to an in‑office biologics and injection service line: J3111 (romosozumab) and J0897 (denosumab) are high‑cost, provider‑administered injections commonly used in bone‑health management, and supporting codes such as 96372 and 96365 document frequent in‑office administration and infusion activity. These clinical code choices suggest the provider’s operations prioritize specialty drug administration clinics or injection sessions alongside routine outpatient visits.

The provider is a national outlier for key biologic injections: J3111 ranks #2 of 970 providers (100th percentile; extreme outlier, far above typical national volume for this code) and J0897 ranks #13 of 10057 providers (100th percentile; extreme outlier, far above typical national volume for this code). Those ranks and percentiles indicate dominant national volume for these specific injectable products rather than modest local participation.

Procedural administration codes also show outsized volume and support the injectable-focused profile: 96372 has 2K claims, $12 avg paid/claim, $24.3K revenue (0.8%) and ranks #62 of 58224 providers (100th percentile; extreme outlier, far above typical national volume for this code), while J3489 (zoledronic acid) ranks #1 of 3032 providers (100th percentile; extreme outlier) with $15.3K revenue. The combination of high ranks on both drug and administration codes points to high throughput in delivering injectable therapies.

Office evaluation-and-management activity exists but is a secondary revenue driver: 99214 shows 732 claims, $90 avg paid/claim, $65.9K revenue (2.2%) and ranks #23871 of 479517 providers (95th percentile; notably above typical national volume for this code). This suggests the provider maintains a meaningful level of longitudinal outpatient care, but E/M revenue is small compared with biologics revenue.

The provider has an established NPI tenure, enumerated 2007-01-29 (~19 years ago), which supports interpretation that the injectable/biologics pattern is not new or transient under this NPI. Longevity combined with concentrated specialty drug billing is consistent with an established practice focus on in‑office administration of bone‑health biologics.

Operational and payer implications follow from the concentration: because J3111 and J0897 dominate revenue ($1.7M and $1.1M respectively within the Medicare $3M total), reimbursement policy changes, prior‑authorization practices, or shifts in prescribing guidelines for these biologics could materially affect this provider’s Medicare revenue. Coupled with having no Medicaid billing on file, the provider faces concentrated payer and product exposure that would be important for contracting and utilization reviews.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

10 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3111	Injection, romosozumab-aqqg, 1 mg	212,520	$10	$1.7M
J0897	Injection, denosumab, 1 mg	60,540	$20	$1.1M
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	730	$90	$65.9K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	2,030	$10	$24.3K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	510	$50	$23.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	160	$130	$20.9K
J3489	Injection, zoledronic acid, 1 mg	2,550	$10	$15.3K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	70	$130	$9.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	130	$70	$8.4K
99221	The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a straightforward or low level of medical…	50	$70	$3.4K

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Barry Jacobson — 7 of 10 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

10 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3111	1	60	16,590	$10	$176.8K
J0897	1	530	2,460	$20	$89.6K
99214	696	23,230	100	$80	$14.5K
99215	2,049	7,170	40	$120	$8.6K
99213	6,943	22,370	70	$60	$7.7K
96365	4	310	70	$50	$5.3K
99204	271	10,290	30	$110	$5K
99221	129	1,500	20	$60	$1.7K
J3489	1	100	120	$10	$1K
96372	1	1,480	50	$10	$1K

Related Providers

Other providers that share a Tax Identification Number (TIN) with Barry Jacobson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Main Line Healthcare	PA	Family Medicine Physician	$0	$8.2M
Daniel Lin	PA	Family Medicine Physician	$127.1K	$2.4M
Nicholas Dzebolo	CA	Interventional Cardiology Physician	$2.2M	$170
Thais Moldovan	PA	Rheumatology Physician	$1.1M	$0
Jennifer Armstrong	PA	Medical Oncology Physician	$545.2K	$0
Amanulla Khaji	PA	Hospitalist Physician	$528.3K	$4.6K
Theodore Plush	NJ	Pulmonary Disease Physician	$482.8K	$0
Courtney Stull	CA	Rheumatology Physician	$446.6K	$360
Raffi Megerian	PA	Internal Medicine Physician	$367.3K	$0
Jason Bradley	PA	Cardiovascular Disease Physician	$366.9K	$0

Nearby Providers

Other providers in the same ZIP code as Barry Jacobson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Arum Healthcare Services	PA	Home Health Agency	$0	$12.5M
Nehal Gandhi	PA	Rheumatology Physician	$8M	$0
Anthony Rooklin	PA	Allergy & Immunology Physician	$1.3M	$0
David Thomas	PA	Neurology Physician	$477.3K	$0
Eric Smith	PA	Orthopaedic Surgery Physician	$430.7K	$0
Kari Boucher	PA	Dermatology Physician	$312.2K	$0
Sarah Tonelli	PA	Dermatology Physician	$302.6K	$0
Robin Scheiner	PA	Dermatology Physician	$286K	$0
Lisa Carroll	PA	Dermatology Physician	$258.7K	$0
John Luksch	PA	Sports Medicine (Family Medicine) Physician	$239.1K	$0

Barry Jacobson — Billing Profile & Reimbursement Data

Sign up for Barry Jacobson — Billing Profile & Reimbursement Data policy alerts

Barry Jacobson — Billing Profile & Reimbursement Data

Sign up for Barry Jacobson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References